Presentation by Da Ren, BioTherapeutics Solutions: MAM, An Eight Year Overview
Presentation by Da Ren, BioTherapeutics Solutions: MAM, An Eight Year Overview
Presentation by Da Ren, BioTherapeutics Solutions: MAM, An Eight Year Overview
Presentation by Krisztina Radi & Ilker Sen, Protein Metrics: Spotting the Outliers in MAM Runs Automatically with Deep Query and…
Presentation by Hirsh Nanda, Janssen: Lab-of-the-Future: A Robotic and Cloud-Based Analytical Pipeline for High-Throughput Characterization of Biologics
Presentation by Jennifer Zhang, Genentech: Enabling MAM for Control System Testing: A Case Study for Commercial Launch Readiness
Presentation by Brian Gau, Pfizer: Oligonucleotide Mapping via LC-UV-MS/MS to Enable Comprehensive Primary Structure Characterization of mRNA Drug Substance
Presentation by Sarah Rogstad, FDA: The Use of Mass Spectrometry in Therapeutic Protein Biologics License Applications: A Retrospective Review Revisited
Presentation by Vamsi Kandhi, Pfizer: A Comprehensive Approach: MAM for Product and Process Understanding
Presentation by Brian Gfeller, Pfizer: Application of HT-MS to Support Process Analytical Characterization
Presentation by Sara Carillo, NIBRT: Characterizing AAV Quality Attributes Using Mass Spectrometry
Presentation by Bingchuan Wei, Genentech: Unveiling Structural-Function Relationship through Hydrogen Deuterium Exchange Coupled with Mass Spectrometry (HDX-MS)